This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Pomegranate
- DrugBank Accession Number
- DB14317
- Background
Pomegranate is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
- Type
- Biotech
- Groups
- Experimental, Investigational
- Synonyms
- Ae-pomegrante
- Allergenic Extract- Pomegranate Punica Granatum
- Dadima Fruit
- Pomegranate Extract
- Pomegranate Fruit
- Pomegranate Fruit Polyphenol Extract
- Pomegranates, Raw
- Pomegranates,raw
- Punica Granatum Fruit
- Punica Granatum Fruit Extract
- Shi Liu Fruit
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Red Cleo Liquid 1 mg/1mL Topical Health-Love Co. 2013-07-02 2017-01-01 US 
Red Cleo Jelly 44.335 g/100g Oral HLscience Co Ltd 2016-04-05 2018-02-12 US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Frudia Pomegranate Nutri Moisturizing Mask Pomegranate (12.57 g/27mL) + Adenosine (0.01 g/27mL) Patch Topical Welcos Co.,ltd. 2016-10-10 Not applicable US Frudia Pomegranate Nutri Moisturizing Serum Pomegranate (31.99 g/50g) + Adenosine (0.02 g/50g) Cream Topical Welcos Co.,ltd. 2016-10-10 Not applicable US Frudia Pomegranate Nutri Moisturizing Toner Pomegranate (170.7 g/195mL) + Adenosine (0.07 g/195mL) Liquid Topical Welcos Co.,ltd. 2016-10-10 Not applicable US - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Frudia Pomegranate Nutri Moisturizing Mask Pomegranate (12.57 g/27mL) + Adenosine (0.01 g/27mL) Patch Topical Welcos Co.,ltd. 2016-10-10 Not applicable US Frudia Pomegranate Nutri Moisturizing Serum Pomegranate (31.99 g/50g) + Adenosine (0.02 g/50g) Cream Topical Welcos Co.,ltd. 2016-10-10 Not applicable US Frudia Pomegranate Nutri Moisturizing Toner Pomegranate (170.7 g/195mL) + Adenosine (0.07 g/195mL) Liquid Topical Welcos Co.,ltd. 2016-10-10 Not applicable US Red Cleo Pomegranate (1 mg/1mL) Liquid Topical Health-Love Co. 2013-07-02 2017-01-01 US Red Cleo Pomegranate (44.335 g/100g) Jelly Oral HLscience Co Ltd 2016-04-05 2018-02-12 US
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 56687D1Z4D
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
- 1246101
- Wikipedia
- Pomegranate
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Treatment Oral Lichen Planus 1 2 Active Not Recruiting Treatment Syndrome, Metabolic 1 2 Completed Prevention PSA Level Less Than or Equal to Fifteen / PSA Level Less Than Ten / Stage I Prostate Cancer AJCC v7 / Stage II Prostate Cancer AJCC v7 / Stage IIA Prostate Cancer AJCC v7 / Stage IIB Prostate Cancer AJCC v7 1 2 Terminated Treatment Cardiomyopathy / Heart Failure 1 2 Unknown Status Treatment Follicular Lymphoma ( FL) 1 1 Unknown Status Treatment Benign Prostatic Hyperplasia (BPH) 1 1 Unknown Status Treatment Skin and Subcutaneous Tissue Disorders 1 Not Available Completed Prevention Gingivitis 1 Not Available Completed Treatment Prostate Cancer 1 Not Available Unknown Status Treatment Atherosclerosis / Diabetes Mellitus 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Patch Topical Cream Topical Liquid Topical Jelly Oral 44.335 g/100g Liquid Topical 1 mg/1mL Capsule Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at July 05, 2018 17:13 / Updated at June 12, 2020 16:53